Àngels López
Senior Technician at the Biomimetic systems for cell engineering Research Group
Data límit: 08/02/2021
Ref: ST_EM
Biomimetic systems for cell engineering Group is looking for a Senior Technician to develop a project on the impact of substrate-derived cues in the self-organization of intestinal epithelia. The contract will be within the framework of the COMIET project, whose objective is to develop biomimetic in vitro models of intestinal epithelia.
The “Crazy about Bioengineering” is back, with a new program!
New year, new program! This is the new course of the “Crazy about Bioengineering” that this year welcomes 24 high school students from different schools throughout Catalonia, with the aim of promoting and consolidating the scientific vocation among young students.
BIST and UIC Barcelona recruit six researchers through the FBA Fellows. James Eills from the University of Southampton will join IBEC
The Barcelona Institute of Science and Technology (BIST) and the Universitat International de Catalunya (UIC Barcelona) have recruited six researchers through the FBA Fellows programme, backed by the Bosch Aymerich Foundation, which aimed at promoting outstanding scientific teaching and research in the fields of health and environment.
Laboratory Assistant at the Targeted Therapeutics and Nanodevices Research Group
Data límit: 05/02/2021
Ref: LA_SM
The Targeted Therapeutics and Nanodevices Groupis looking for a research assistant to help the lab with a project relative to the development of biodegradable polymer nanoparticles for encapsulation of therapeutic proteins and targeting to specific cells .
PhD position in the Rizzello/Battaglia Research Group
Data límit: 31/01/2021
Ref: PhD_LR
The group led by Loris Rizzello and Giuseppe Battaglia (IBEC) is looking for a Predoctoral researcher to investigate the pathophysiology of Tuberculosis in order to decipher the host-pathogens interactions during the infectious process.
Two IBEC projects granted by “Knowledge Industry Call” of the Catalan Government
A project led by Elisabeth Engel aimed to fabricate and test a dressing prototype for wound healing, and another project led by Javier Ramón with the goal of developing an artificial liver, have been granted by the Knowledge Industry Programme of the Catalan Government.
Josep Samitier “A country that invests in science will have more welfare opportunities”
Josep Samitier, director of the Institute for Bioengineering of Catalonia and president of ACER, speaks in various media about the lack of public investment in research.
Postdoctoral position on microscopy at the Bioengineering in Reproductive Health Research Group
Application Deadline: 31/01/2021
Ref: PD-SO
The Bioengineering in reproductive health group at the Institute for Bioengineering of Catalonia (IBEC) offers a Postdoctoral position for an optics physicist or engineer with experience in advance microcopy and image analysis. The project involves using label-free imaging for the study of human embryos.
This project aims to address the diagnostic limitations in IVF clinics and develop an objective, quantitative imaging technology capable to discriminate competent embryos. The method will be based on label-free microscopy. The biological data will be extracted from microscopy measurements of the embryos, via different image processing and statistical correlation procedures. Biological samples are naturally auto-fluorescent due to the presence of different molecules which are crucial for the embryonic development. The goal of this project is to use the endogenous signals from the embryo in a non-invasive way to extract meaningful biological information. The results of this project will be the basis for the creation of a biotech spin-off.
Our laboratory is a multidisciplinary environment where biologists, physicists, clinicians and business developers synergize to create a unique environment shaped by science and entrepreneurship. Due to the high translational component of our research, we have established collaboration contracts with the pharma industry, hospitals and venture capital to bring our technology to the clinics and the market